Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 13, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06405828). This is a study registration, not published results. Lead sponsor: Icahn School of Medicine at Mount Sinai. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 67 participants (ESTIMATED). Conditions: Metastatic Breast Cancer, Stage IV Breast Cancer AJCC V7. Interventions: BEHAVIORAL: ACCESS Supportive Care; BEHAVIORAL: Phone sessions. Primary outcome measures: Number of participants recruited , at 9 months; Number of participants remaining in study , at 9 months; Number of times navigator communicates with oncology team , 9 months; Number of times participants connect to resources , 9 months; Number of visits , 6 months; Number of phone calls , 9 months; Number of visits conducted according to the ACCESS manual , 9 months; Change in The Impact of Event Scale - Revised (IES-R) scores , Baseline and 9 months; Change in The Memorial Symptom Assessment Scale (MSAS) , Baseline and 9 months. Brief summary: Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women with metastatic breast cancer.